Carnitine metabolic enzymes

Carnitine metabolic enzymes represent a group of proteins essential for the regulation of long-chain fatty acid metabolism and energy production. The primary components include the carnitine palmitoyltransferases (CPT1 and CPT2), which facilitate the transport of fatty acids into the mitochondria via the carnitine shuttle, and biosynthetic enzymes such as gamma-butyrobetaine dioxygenase (BBOX1) and trimethyllysine hydroxylase (TMLHE) (Source: UniProt, PubMed: 25598302). These enzymes are critical therapeutic targets because many cancer cells rely on CPT1-mediated fatty acid oxidation for survival and drug resistance, while inhibition of carnitine synthesis or transport is used to treat cardiovascular conditions by shifting myocardial metabolism from fatty acids to glucose (Source: PubMed: 30039145, StatPearls). Pharmacological agents like Etomoxir and Meldonium target these enzymes to modulate metabolic flux, though clinical use is often limited by potential side effects such as hepatotoxicity and metabolic derangement (Source: PubChem, PubMed: 29070557).

Other names

Carnitine shuttle enzymesCarnitine systemFatty acid transport enzymesCarnitine biosynthetic enzymes

Inhibition of carnitine palmitoyltransferase 1 (CPT1) to suppress mitochondrial fatty acid entry and oxidation; inhibition of gamma-butyrobetaine dioxygenase (BBOX1) to reduce endogenous carnitine biosynthesis.